Key result
Complete resection of rare pediatric chest wall synovial sarcoma yields 3-year survival without adjuvant therapy.
Case Report (n=1)
Complete resection of a rare chest wall synovial sarcoma in a child resulted in 3-year disease-free survival without adjuvant therapy.
Hypothesis-generating for omitting adjuvant therapy after complete resection in rare pediatric cases; should not change practice pending larger studies.
Synovial sarcoma is a malignant soft-tissue tumor that most commonly occurs in the extremities of young adults. There have been several cases of synovial sarcomas of the pleural and lung reported, but synovial sarcoma arising from the chest wall in childhood is very rare. Here we report a case of synovial sarcoma arising from the chest wall in a 3 year-old female patient. The tumor was completely resected. No adjuvant therapy was given. The patient is well 3 years after the operation.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2010) conducted a case report in Synovial sarcoma of the chest wall (n=1). Complete resection was evaluated. Complete resection of a rare chest wall synovial sarcoma in a 3-year-old female resulted in the patient remaining well at 3 years post-operation without adjuvant therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: